Vincenza Nigro
Corporate Officer/Principal presso HANSA BIOPHARMA AB
Posizioni attive di Vincenza Nigro
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| HANSA BIOPHARMA AB | Corporate Officer/Principal | 17/09/2018 | - |
| Direttore Tecnico/Scientifico/R&S | 17/09/2018 | - |
Storia della carriera di Vincenza Nigro
Precedenti posizioni note di Vincenza Nigro
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Vincenza Nigro
| Fairleigh Dickinson University | Undergraduate Degree |
| Massachusetts Institute of Technology | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Danimarca | 2 |
| Svezia | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HANSA BIOPHARMA AB | Health Technology |
| Aziende private | 1 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Vincenza Nigro
- Esperienza
